
Rat breeding in RV linked to fatal infection
A man who bred rats in an RV in Berkeley died from leptospirosis, prompting health alerts as the city reports its first human cases in more than a decade.

A man who bred rats in an RV in Berkeley died from leptospirosis, prompting health alerts as the city reports its first human cases in more than a decade.

Google ships Android 17 QPR1 Beta 4 to Pixel phones, signaling a stability-focused cycle with minor interface changes and deeper hooks into Google's own services.
2026-06-11

Both short and long sleep are linked to higher disease risk. Most adults function best around seven hours, with brain and metabolic markers worsening as you move away from that midpoint.
2026-06-11

A leading OB-GYN group released vaccine guidance for pregnancy that departs from US government advice, exposing gaps in evidence, risk tolerance, and communication strategy.
2026-06-11

Apple outlines over 250 changes across iOS, macOS, watchOS, tvOS, and visionOS, focusing on AI, continuity, accessibility, and media while targeting a broad fall release window.
2026-06-11

Colorado health officials report a rare rabbit- and tick-linked illness, expand testing and surveillance, and warn residents to avoid contact with sick wildlife.
2026-06-11

Apple and Google are adding support for Thread 1.4, a move that steers the smart home toward a single, border-router-agnostic mesh network for Matter devices.
2026-06-11

Apple is recasting Siri as a terse, context-aware assistant that trims chatter, shortens answers and times its silence to feel more like a focused tool than a chatty companion.
2026-06-11

Sapient’s 1B-parameter model, trained on only 40B tokens for about $1,500, posts reasoning scores close to larger 2B–7B systems, raising sharp questions about current scaling and pretraining budgets.
2026-06-11

Investors should move beyond injectable GLP‑1 leaders, focus on oral and multi‑agonist pipelines, and model U.S. access and pricing shifts that may reshape Lilly’s weight‑loss dominance.
2026-06-11

A longevity startup has dosed the first human with ER‑100, a cell‑reprogramming therapy designed to reverse age‑related sight loss by targeting cellular aging pathways.
2026-06-10